NPPA directed all manufacturers and importers of coronary stents whose retail prices are lower than the ceiling set by it to ...
Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...
Modesto Bee on MSN14h
Stanislaus County’s top physician says Modesto has good atmosphere for practicing medicineThe Stanislaus Medical Society is recognizing the career of a leading cardiologist in Modesto. Dr. Satnam Ludder is receiving ...
Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...
Abbott (NYSE: ABT) received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy ...
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...
Due to advancements spurred by AI/ML, the impact of digital health technology will grow. Data from the Department for Promotion of Industry and Internal Trade show that FDI in the medicines and ...
The global bioabsorbable stents market size was US$ 221.5 million in 2021. The global bioabsorbable stents market is forecast to grow to US$ 351.5 million by 2030 by growing at a compound annual ...
Prospective Multicenter Study Investigates Ringer™ PBC for Management of Coronary PerforationsWAYNE, Pa., March 27, 2025 ...
Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback